The global rainbow trout market is expected to surpass US $7 billion by the end of 2033, with a CAGR of 5.2 percent. It is currently valued at US $4.2 billion. Fresh rainbow trout has been consistently performing better than frozen and canned varieties as it is highly adaptable and has an infinite variety of preparation options.
The primary growth driver for rainbow trout is its nutritional advantages. In addition to high protein levels, rainbow trout are high in vitamin B, potassium, phosphorus, selenium, and omega-3 fatty acids.
Top rainbow trout producers are currently emphasising strategic marketing and advertising diversification of current offerings. Partnerships with local players are important, but a number of companies are tapping into off-shore imports to deal with demand. Aquaculture sites are being developed in high-demand regains, and investment in research is developing the industry’s efficiency. For example, in 2022, Vermont Fish & Wildlife began testing the new Eagle Lake strain to see if it outperforms the Erwin-Arlee strain of rainbow trout.
